Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06095817 · ClinicalTrials.gov registry record · NA
Project VALOR: Veteran Stress and Wellbeing
A NA study, sponsored by Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT06095817: Clinical Trial NA study, sponsored by Cornell University.
NCT06095817 is a NA study that was terminated before completion, run by Cornell University. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06095817, a NA study, was terminated before completion, sponsored by Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
This study will examine the efficacy of an internet-based brief intervention designed to reduce risky behavior veterans as the move into their second year post-Army. Up to 350 veterans drawn from The Network Study (Dept of Defense; Award number: W81XWH1920001) will be recruited with the intention of drawing a final sample of 300. Study participants will be randomly assigned to either the intervention or the control group, stratified by age and gender.
Primary Outcome
Single Alcohol Screening Question (SASQ) (Williams and Vinson, 2001)
Interventions
- BEHAVIORAL Internet Delivered Brief Intervention (IDBI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2023-10-06 |
| Phase | NA |
Why NCT06095817 stopped before completion
NCT06095817 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Internet Delivered Brief Intervention (IDBI) is the first listed.
NCT06095817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06095817 about?
NCT06095817 is a clinical study titled "Project VALOR: Veteran Stress and Wellbeing". This study will examine the efficacy of an internet-based brief intervention designed to reduce risky behavior veterans as the move into their second year post-Army. Up to 350 veterans drawn from The Network Study (Dept of Defense; Award number: W81XWH1920001) will be recruited with the intention of...
What is the current status of trial NCT06095817?
This trial is currently terminated. It is a NA study. The enrollment target is 140 participants. The study started on 2023-06-01. Estimated completion is 2023-10-06.
What interventions are being tested in trial NCT06095817?
The interventions under investigation include: Internet Delivered Brief Intervention (IDBI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06095817?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06095817's enrollment target sits among peer trials
140 713th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI